Trade Summary

3 days ago, Gault Cheryl, serving as Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 10,000 shares at $41.58 per share, for a total transaction value of $415,797.77. Following this transaction, Gault Cheryl now holds 149,914 shares of RAPP.

This sale represents a 6.25% decrease in Gault Cheryl's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 30, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:10 PM ET, 1 day after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.